Viewing Study NCT00855920


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-02-22 @ 8:14 AM
Study NCT ID: NCT00855920
Status: COMPLETED
Last Update Posted: 2017-04-28
First Post: 2009-02-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study Utilizing Rilonacept in Gout Exacerbations
Sponsor: Regeneron Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: IL1T-GA-0814
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators